Halotestin

   
Google
 
Web NewDrugInformation.com

Halotestin


Drug - Halotestin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fluoxymesterone
Multiple ingredients are in alphabetical order.

Strength - 2MG
The potency of the active ingredient(s), Fluoxymesterone. May repeat for multiple part products.

Applicant - PHARMACIA AND UPJOHN
The firm name holding legal responsibility for Halotestin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010611
The FDA assigned number to Halotestin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Halotestin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Halotestin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Halotestin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Halotestin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Halotestin.

Halotestin